Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065222

President & CEO sold 42,773 shares at $13.16 ($562,893)

  • President & CEO acquired 94,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2021-11-15 Grant or award +94,100 518,223 D: show line 1 in the form
ROBIN HOWARD W President & CEO 2021-11-16 Sale −42,773 $13.16 $562,893 475,450 D: show line 2 in the form
Open-market sales · 42,773 sh · avg $13.16 · $562,893
Loading xslF345X03/doc4.xml…